Improving Outcomes for Juvenile Idiopathic Arthritis
Improving Outcomes for Children Newly Diagnosed With Juvenile Idiopathic Arthritis Through a Structured Support Program (JASP-1) - A Longitudinal Register Study
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Stockholm、スウェーデン、17176
- Karolinska University Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 子
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- For the JASP-1: Diagnosed with JIA and have completed the JASP-1.
- For the control group: Diagnosed with JIA at the same clinic as above
Exclusion Criteria:
- No JIA diagnosis
- Change of diagnose during the year
- Do not understand or speak Swedish
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：非ランダム化
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Participating in the Juvenile Arthritis Support Program (JASP-1)
Children newly diagnosed with JIA and their parents were invited to participate in the intervention JASP-1.
The intervention contains seven structured patient-and family centered visits the first year after JIA diagnose.
With more visits close in the beginning.
|
Seven structured visits with a patient-and family-centered approach was used in the JASP-1 program, in which children newly diagnosed with JIA and their parents were invited to participate in.
|
|
介入なし：Control group
This arm is a control group consisting of 60 children matched in diagnose, gender and age with the ones in the intervention group.
The children and parents in the control group did not receive any intervention.
The data was collected from the PedSRQ register.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
CHAQ, Disabkids, Physicians global assessment
時間枠：For one year following JIA diagnosis
|
56 children received JASP-1and was on 3 timepoints compared with 60 children matched in disease, gender and age.The measures compared is CHAQ including pain, disease impact on overall well-being and school attendance, DISABKIDS, JADAS-71, Physicians global assessment, Number of active joints, Number of joint injections and Pharmacological treatment. Outcomes at 12 months, were analyzed using the non parametric Mann-Whitney U test. For categorical variables differences were analyzed using the chi-square test to compare proportions. Repeated measurement ANOVA was used for calculating differences over time between the two groups. P value < 0.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics for Windows, version 31. |
For one year following JIA diagnosis
|
|
CHAQ
時間枠：Assessed several times during the first year after diagnosis. Values from 0-3
|
Childhood Health Assessment Queationnaire
|
Assessed several times during the first year after diagnosis. Values from 0-3
|
|
Disabkids
時間枠：Assessed at 3 timepoints during the first year, values between 0-100
|
Health Related Quality of Life
|
Assessed at 3 timepoints during the first year, values between 0-100
|
|
Phycisians global assessment
時間枠：During the first year after diagnosis
|
Assessed at 3 timepoint during the first year after diagnosis.
Valued on a VAS scale 0-10
|
During the first year after diagnosis
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- K 2026-0525
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。